• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅基于川崎病后冠状动脉z评分对冠状动脉异常进行的改良分类。

Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.

作者信息

Manlhiot Cedric, Millar Kyle, Golding Fraser, McCrindle Brian W

机构信息

Division of Cardiology, Department of Pediatrics, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G-1X8, Canada.

出版信息

Pediatr Cardiol. 2010 Feb;31(2):242-9. doi: 10.1007/s00246-009-9599-7. Epub 2009 Dec 19.

DOI:10.1007/s00246-009-9599-7
PMID:20024653
Abstract

Competing definitions and classifications of coronary artery abnormalities (CAAs) after Kawasaki disease (KD) have been arbitrarily defined based on clinical experience. We sought to propose a classification system for CAAs based only on coronary artery z-scores. All echocardiograms performed between 1990 and 2007 on patients with a previous history of KD were reviewed. Coronary artery luminal dimensions were converted to body-surface-area-adjusted z-scores and compared to current classification systems. A total of 1356 patients with a previous history of KD underwent 4379 echocardiograms. There was important overlap in the distributions of coronary artery z-scores between the different CAA classes as defined by the American Heart Association (AHA). The AHA classification underestimated the severity of CAAs in 19-32% of small CAAs and 35-78% of medium CAAs. We determined the optimal definition of CAA to be small if the z-score is >or=2.5 to <5.0, large if the z-score is >or=5.0 to <10.0, and giant if the z-score is >or=10.0. This classification seems to appropriately apply to the circumflex branch despite a lack of normal values for this branch. The current AHA classification might not accurately classify CAAs in KD patients. Accurate classification is important for defining management and prognosis consistently across patient age and size.

摘要

川崎病(KD)后冠状动脉异常(CAA)的竞争性定义和分类一直是基于临床经验随意确定的。我们试图提出一种仅基于冠状动脉z评分的CAA分类系统。回顾了1990年至2007年间对有KD既往史患者进行的所有超声心动图检查。将冠状动脉管腔尺寸转换为经体表面积调整的z评分,并与当前的分类系统进行比较。共有1356例有KD既往史的患者接受了4379次超声心动图检查。在美国心脏协会(AHA)定义的不同CAA类别之间,冠状动脉z评分的分布存在重要重叠。AHA分类低估了19%至32%的小CAA和35%至78%的中CAA的严重程度。我们确定,如果z评分≥2.5至<5.0,则CAA的最佳定义为小;如果z评分≥5.0至<10.0,则为大;如果z评分≥10.0,则为巨大。尽管该分支缺乏正常值,但这种分类似乎适用于回旋支。当前的AHA分类可能无法准确对KD患者的CAA进行分类。准确分类对于在不同年龄和体型的患者中一致地确定治疗和预后很重要。

相似文献

1
Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.仅基于川崎病后冠状动脉z评分对冠状动脉异常进行的改良分类。
Pediatr Cardiol. 2010 Feb;31(2):242-9. doi: 10.1007/s00246-009-9599-7. Epub 2009 Dec 19.
2
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.川崎病后冠状动脉瘤的中期并发症:来自国际川崎病注册研究。
J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28.
3
Assessment of coronary artery abnormalities and variability of Z-score calculation in the acute episode of Kawasaki disease-A retrospective study from China.评估川崎病急性期冠状动脉异常及 Z 评分计算的变异性:来自中国的回顾性研究。
Eur J Clin Invest. 2021 Mar;51(3):e13409. doi: 10.1111/eci.13409. Epub 2020 Sep 25.
4
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline Scores.北美某中心对川崎病患者冠状动脉瘤的预测:基线评分评估
J Am Heart Assoc. 2017 May 31;6(6):e005378. doi: 10.1161/JAHA.116.005378.
5
Implications of Changing Z-Score Models for Coronary Artery Dimensions in Kawasaki Disease.川崎病冠状动脉形态改变的 Z 评分模型的意义。
Pediatr Cardiol. 2021 Feb;42(2):432-441. doi: 10.1007/s00246-020-02501-0. Epub 2021 Jan 4.
6
Etiology and prognosis of non-Kawasaki disease induced coronary aneurysms in children: a retrospective case series study.儿童非川崎病相关性冠状动脉瘤的病因和预后:一项回顾性病例系列研究。
Eur J Pediatr. 2024 Oct;183(10):4229-4234. doi: 10.1007/s00431-024-05666-5. Epub 2024 Jul 11.
7
Time Course of Coronary Artery Aneurysms in Kawasaki Disease.川崎病冠状动脉瘤的时间进程。
J Pediatr. 2021 Mar;230:133-139.e2. doi: 10.1016/j.jpeds.2020.12.004. Epub 2020 Dec 8.
8
Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.川崎病冠状动脉瘤预测的危险因素和评分:一项欧洲单中心研究。
BMC Pediatr. 2024 Feb 23;24(1):139. doi: 10.1186/s12887-024-04623-3.
9
Coronary artery dilation after Kawasaki disease for children within the normal range.川崎病患儿冠状动脉正常范围内扩张。
Int J Cardiol. 2009 Jul 24;136(1):27-32. doi: 10.1016/j.ijcard.2008.04.019. Epub 2008 Jul 11.
10
Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms.川崎病合并动脉瘤患者超声心动图与心脏 CT 冠状动脉测量的比较。
J Cardiovasc Comput Tomogr. 2022 Jan-Feb;16(1):43-50. doi: 10.1016/j.jcct.2021.09.002. Epub 2021 Sep 16.

引用本文的文献

1
Long-term cardiovascular outcomes and mortality following Kawasaki disease: A systematic review and meta-analysis.川崎病后的长期心血管结局和死亡率:一项系统评价和荟萃分析。
Paediatr Child Health. 2025 Mar 27;30(5):406-413. doi: 10.1093/pch/pxaf003. eCollection 2025 Aug.
2
Association Between Thymosin β4 and Coronary Arterial Lesions in Children with Kawasaki Disease.川崎病患儿胸腺素β4与冠状动脉病变的关系
J Inflamm Res. 2025 Jul 3;18:8755-8765. doi: 10.2147/JIR.S519589. eCollection 2025.
3
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki Disease.

本文引用的文献

1
Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease.川崎病后冠状动脉病变患者内皮功能障碍和亚临床动脉粥样硬化的年龄相关加速
Pediatr Cardiol. 2009 Apr;30(3):262-8. doi: 10.1007/s00246-008-9329-6. Epub 2008 Nov 20.
2
Coronary artery dilation after Kawasaki disease for children within the normal range.川崎病患儿冠状动脉正常范围内扩张。
Int J Cardiol. 2009 Jul 24;136(1):27-32. doi: 10.1016/j.ijcard.2008.04.019. Epub 2008 Jul 11.
3
Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease.
儿童多系统炎症综合征与川崎病冠状动脉受累情况对比
J Am Heart Assoc. 2025 May 6;14(9):e037761. doi: 10.1161/JAHA.124.037761. Epub 2025 Apr 23.
4
Long-term health-related quality of life in Kawasaki disease complicated with coronary artery aneurysm in the Nanjing region of China: Results of the largest single-center assessment.中国南京地区川崎病合并冠状动脉瘤患者的长期健康相关生活质量:最大规模单中心评估结果
Arch Rheumatol. 2024 Dec 12;39(4):549-557. doi: 10.46497/ArchRheumatol.2024.10546. eCollection 2024 Dec.
5
[Diagnosis of coronary artery lesions in children based on Z-score regression model].基于Z评分回归模型的儿童冠状动脉病变诊断
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Feb 15;27(2):176-183. doi: 10.7499/j.issn.1008-8830.2405030.
6
Long-Term Health-Related Quality of Life in Kawasaki Disease-Related Coronary Artery Aneurysm: A Large Single-Center Assessment in Nanjing, China.川崎病相关冠状动脉瘤的长期健康相关生活质量:中国南京的一项大型单中心评估
Tex Heart Inst J. 2025 Feb 4;52(1):e248393. doi: 10.14503/THIJ-24-8393. eCollection 2025 Jan-Jun.
7
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
8
Diagnostic value of syndecan-1 for coronary artery lesions and correlation analysis of laboratory indicators in Kawasaki disease patients.血清透明质酸酶-1 对川崎病患者冠状动脉病变的诊断价值及实验室指标的相关性分析。
Ital J Pediatr. 2024 Oct 9;50(1):209. doi: 10.1186/s13052-024-01772-0.
9
Evaluating the performance of egami, kobayashi and sano scores in predicting IVIG resistance in infant kawasaki disease.评估 egami、小林和佐野评分在预测婴儿川崎病 IVIG 抵抗中的表现。
BMC Pediatr. 2024 Sep 28;24(1):606. doi: 10.1186/s12887-024-05035-z.
10
The Effectiveness of No or Low-Dose versus High-Dose Aspirin in Treating Acute Kawasaki Disease: A Systematic Review and Meta-Analysis.低剂量或无剂量与高剂量阿司匹林治疗急性川崎病的疗效:一项系统评价和荟萃分析
Clin Pract. 2024 Jul 3;14(4):1296-1309. doi: 10.3390/clinpract14040105.
华法林治疗巨大动脉瘤可预防川崎病中的心肌梗死。
Pediatr Cardiol. 2008 Mar;29(2):398-401. doi: 10.1007/s00246-007-9132-9. Epub 2007 Nov 20.
4
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.川崎病患儿的冠状动脉受累情况:基于系列标准化测量分析的危险因素
Circulation. 2007 Jul 10;116(2):174-9. doi: 10.1161/CIRCULATIONAHA.107.690875. Epub 2007 Jun 18.
5
Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations.剪应力降低和血流紊乱可能导致冠状动脉瘤和血栓形成。
Pediatr Int. 2007 Feb;49(1):1-7. doi: 10.1111/j.1442-200X.2007.02312.x.
6
Kawasaki disease, myocardial infarction and coronary artery revascularization.川崎病、心肌梗死与冠状动脉血运重建
Can J Cardiol. 2005 May 15;21(7):601-4.
7
Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.川崎病继发巨大动脉瘤患者的长期预后。
J Rheumatol. 2005 May;32(5):928-34.
8
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会给卫生专业人员的声明
Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78.
9
Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening.急性川崎病期间冠状动脉扩张超过4.0毫米预示着随后发生晚期内膜中层增厚的可能性很高。
Pediatr Cardiol. 2002 Jan-Feb;23(1):9-14. doi: 10.1007/s00246-001-0004-4. Epub 2002 Feb 19.
10
Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque.导致冠状动脉粥样硬化进展和易损斑块形成的血管内血流动力学因素。
Curr Opin Cardiol. 2000 Nov;15(6):430-40. doi: 10.1097/00001573-200011000-00010.